It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"

The movement for a national pharmacare plan in Canada is growing, but at the same time the multinational pharmaceutical companies and their supporters are critical of such a move. The three major arguments that they make are that all that is needed is to "fill in the gaps," ie, cover those...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947650/
https://www.ncbi.nlm.nih.gov/pubmed/32610770
http://dx.doi.org/10.15171/ijhpm.2020.03
_version_ 1783663270879559680
author Lexchin, Joel
author_facet Lexchin, Joel
author_sort Lexchin, Joel
collection PubMed
description The movement for a national pharmacare plan in Canada is growing, but at the same time the multinational pharmaceutical companies and their supporters are critical of such a move. The three major arguments that they make are that all that is needed is to "fill in the gaps," ie, cover those who currently are uninsured or underinsured, that private drug plans are superior to public ones because they cover a larger number of drugs and that Canada cannot afford pharmacare. This commentary examines each of these arguments and makes the case that none of them is valid and that it is time to get on with implementing pharmacare.
format Online
Article
Text
id pubmed-7947650
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-79476502021-03-16 It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada" Lexchin, Joel Int J Health Policy Manag Commentary The movement for a national pharmacare plan in Canada is growing, but at the same time the multinational pharmaceutical companies and their supporters are critical of such a move. The three major arguments that they make are that all that is needed is to "fill in the gaps," ie, cover those who currently are uninsured or underinsured, that private drug plans are superior to public ones because they cover a larger number of drugs and that Canada cannot afford pharmacare. This commentary examines each of these arguments and makes the case that none of them is valid and that it is time to get on with implementing pharmacare. Kerman University of Medical Sciences 2020-01-12 /pmc/articles/PMC7947650/ /pubmed/32610770 http://dx.doi.org/10.15171/ijhpm.2020.03 Text en © 2020 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Lexchin, Joel
It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
title It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
title_full It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
title_fullStr It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
title_full_unstemmed It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
title_short It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
title_sort it’s time to finally kill the zombies comment on "universal pharmacare in canada"
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947650/
https://www.ncbi.nlm.nih.gov/pubmed/32610770
http://dx.doi.org/10.15171/ijhpm.2020.03
work_keys_str_mv AT lexchinjoel itstimetofinallykillthezombiescommentonuniversalpharmacareincanada

Ejemplares similares